Skip to content

Clinical trials

Phase 1 Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 1 Country / region: Netherlands Clear all

124 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20053
20064
20077
20086
20097
20105
20118
20124
201312
201410
201510
20163
20177
20187
20195
20204
20215
20224
20232
20246
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed88
Terminated16
Active, not recruiting11
Recruiting6
Not yet recruiting1
Enrolling by invitation1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca13
GlaxoSmithKline12
Hoffmann-La Roche8
Amgen6
Novartis Pharmaceuticals6
AbbVie5
Boehringer Ingelheim5
Bayer4
Sanofi4
Adaptimmune3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms124
Carcinoma, Non-Small-Cell Lung14
Neoplasm Metastasis10
Breast Neoplasms8
Lymphoma, Non-Hodgkin6
Carcinoma, Renal Cell5
Lung Neoplasms5
Squamous Cell Carcinoma of Head and Neck5
Colorectal Neoplasms4
Leukemia, Myeloid, Acute4

Trials

Showing 1 to 25 of 124. Each trial links to its page on Pharma Observatory.

24 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.